Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide and Metformin in Obese Infertile PCOS Women
NCT06742710Phase 4Recruiting
- Sponsor
- Peking University Third Hospital
- Start
- May 2025
- Primary completion
- May 2029
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial of liraglutide in infertility, polycystic ovary syndrome (PCOS) and obesity (2 arms), sponsored by Peking University Third Hospital. Primary endpoint: Live birth rate associated with single cycle frozen embryo transfer. Started May 2025; status: recruiting.
02
Drugs
03
Conditions
infertilitypolycystic ovary syndrome (PCOS)obesity
Beyond the preview
Go deeper on NCT06742710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06742710.